D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 26,148 356 World Ranking 8087 National Ranking 4348

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His main research concerns Cancer research, Pancreatic cancer, Internal medicine, Adenocarcinoma and Cancer. His Cancer research research is multidisciplinary, relying on both Cell culture, Cell growth, Pathology, Regulation of gene expression and Pancreatic disease. His Pancreatic cancer study combines topics in areas such as Cancer cell, Cancer stem cell, Transcription factor, Pancreas and Chemoradiotherapy.

His Internal medicine research incorporates elements of Gastroenterology and Oncology. The Adenocarcinoma study combines topics in areas such as Surgery, Radiation therapy and Pancreaticoduodenectomy. His Cancer research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Epigenetics.

His most cited work include:

  • Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function (637 citations)
  • Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer (619 citations)
  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (600 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Cancer research, Pancreatic cancer, Internal medicine, Oncology and Pathology. His Cancer research research includes elements of Cell growth, Carcinogenesis, Cancer cell, Immunology and KRAS. His Pancreatic cancer study is related to the wider topic of Cancer.

His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems. His research integrates issues of Irinotecan, Pancreatic ductal adenocarcinoma, Gemcitabine, Survival analysis and Cohort in his study of Oncology. His Pathology research includes themes of Metastasis, Pancreatitis and Pancreas.

He most often published in these fields:

  • Cancer research (43.84%)
  • Pancreatic cancer (40.75%)
  • Internal medicine (35.62%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (43.84%)
  • Pancreatic cancer (40.75%)
  • Internal medicine (35.62%)

In recent papers he was focusing on the following fields of study:

Cancer research, Pancreatic cancer, Internal medicine, Cancer cell and Tumor progression are his primary areas of study. His Cancer research study incorporates themes from Carcinogenesis, KRAS, Oncogene and In vivo. Cancer covers he research in Pancreatic cancer.

The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. Huamin Wang interconnects Apoptosis, Small hairpin RNA, Null cell, Gene and Sterol regulatory element-binding protein in the investigation of issues within Cancer cell. His Tumor progression research incorporates themes from Phenotype, STAT3, STAT protein and Immunohistochemistry.

Between 2017 and 2021, his most popular works were:

  • Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. (97 citations)
  • Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. (61 citations)
  • Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells (51 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Huamin Wang focuses on Pancreatic cancer, Cancer research, Cancer cell, Tumor microenvironment and Pancreatic tumor. His Pancreatic cancer study is focused on Internal medicine in general. His work deals with themes such as Carcinogenesis, KRAS, Erlotinib, EGFR inhibitors and RNase P, which intersect with Cancer research.

The concepts of his Cancer cell study are interwoven with issues in Oncogene and Pancreas. His Pancreas research focuses on Transcription factor and how it relates to Cancer. He has included themes like Progenitor cell and Radiology in his Pancreatic tumor study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

Andrea Viale;Piergiorgio Pettazzoni;Costas A. Lyssiotis;Haoqiang Ying.
Nature (2014)

965 Citations

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

Thiruvengadam Arumugam;Vijaya Ramachandran;Keith Francis Fournier;Huamin Wang.
Cancer Research (2009)

898 Citations

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong.
Annals of Surgical Oncology (2006)

879 Citations

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)

801 Citations

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Dan G. Blazer;Yoji Kishi;Dipen M. Maru;Scott Kopetz.
Journal of Clinical Oncology (2008)

639 Citations

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang.
Annals of Surgery (2007)

633 Citations

Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer

Avnish Kapoor;Wantong Yao;Haoqiang Ying;Sujun Hua.
Cell (2014)

572 Citations

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun.
Annals of Surgical Oncology (2009)

512 Citations

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)

505 Citations

KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

Jianhua Ling;Ya'an Kang;Ruiying Zhao;Qianghua Xia.
Cancer Cell (2012)

489 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Huamin Wang

Jean Nicolas Vauthey

Jean Nicolas Vauthey

The University of Texas MD Anderson Cancer Center

Publications: 95

Jason B. Fleming

Jason B. Fleming

The University of Texas MD Anderson Cancer Center

Publications: 92

Douglas B. Evans

Douglas B. Evans

Medical College of Wisconsin

Publications: 76

Herbert J. Zeh

Herbert J. Zeh

The University of Texas Southwestern Medical Center

Publications: 71

Christopher L. Wolfgang

Christopher L. Wolfgang

New York University

Publications: 57

Jeffrey E. Lee

Jeffrey E. Lee

The University of Texas MD Anderson Cancer Center

Publications: 57

Timothy M. Pawlik

Timothy M. Pawlik

The Ohio State University Wexner Medical Center

Publications: 55

Joseph M. Herman

Joseph M. Herman

National Cancer Institute

Publications: 54

Stephen Safe

Stephen Safe

Texas A&M University

Publications: 51

Anirban Maitra

Anirban Maitra

The University of Texas MD Anderson Cancer Center

Publications: 49

Claudio Bassi

Claudio Bassi

University of Verona

Publications: 45

Scott Kopetz

Scott Kopetz

The University of Texas MD Anderson Cancer Center

Publications: 44

Ralph H. Hruban

Ralph H. Hruban

Johns Hopkins University School of Medicine

Publications: 42

Markus W. Büchler

Markus W. Büchler

University Hospital Heidelberg

Publications: 41

Jens Werner

Jens Werner

Ludwig-Maximilians-Universität München

Publications: 39

Surinder K. Batra

Surinder K. Batra

University of Nebraska Medical Center

Publications: 36

Trending Scientists

Hermann Hellwagner

Hermann Hellwagner

University of Klagenfurt

Marcelo Ang

Marcelo Ang

National University of Singapore

Raphaèle Herbin

Raphaèle Herbin

Aix-Marseille University

D. Landolt

D. Landolt

École Polytechnique Fédérale de Lausanne

Rasika A. Mathias

Rasika A. Mathias

Johns Hopkins University

Ralf B. Schäfer

Ralf B. Schäfer

University of Koblenz and Landau

Dieter Marmé

Dieter Marmé

University of Freiburg

Wataru Hashimoto

Wataru Hashimoto

Kyoto University

Satu Pyörälä

Satu Pyörälä

University of Helsinki

Shiyin Liu

Shiyin Liu

Yunnan University

Stephen G. Monismith

Stephen G. Monismith

Stanford University

Bogdan P. Onac

Bogdan P. Onac

University of South Florida

Claus-Christian Carbon

Claus-Christian Carbon

University of Bamberg

Richard Koestner

Richard Koestner

McGill University

Silvio Garattini

Silvio Garattini

Mario Negri Institute for Pharmacological Research

Janine D. Flory

Janine D. Flory

Queens College, CUNY

Something went wrong. Please try again later.